Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria

Cytotechnology

Volumn 67, Issue 3, 2015, Pages 427-435

  Masadeh, Majed M ^a   Karasneh, Ghadah A ^a   Al Akhras, Mohammad A ^a   Albiss, Borhan A ^a   Aljarah, Khaled M ^a   Al azzam, Sayer I ^a   Alzoubi, Karem H ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Antibacterial activity; Biofilm bacteria; Cerium oxide; Ciprofloxacin; Iron oxide; Nanoparticles

Indexed keywords

EID: 84896422216     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-014-9701-8     Document Type: Article

References (42)

1. Aljarrah K, Mhaidat NM, Al-Akhras MA, Aldaher AN, Albiss B, Aledealat K, Alsheyab FM (2012) Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis. World J Surg Oncol 10:62. doi:10.1186/1477-7819-10-62
2. Applerot G, Lellouche J, Perkas N, Nitzan Y, Gedanken A, Banin E (2012) ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and increase antibiotic susceptibility. RSC Adv 2:2314–2321
3. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet P (1999) Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interface Sci 212:474–482. doi:10.1006/jcis.1998.6053jcis.1998.6053
4. Cernohorska L, Votava M (2008) Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa. Folia Microbiol (Praha) 53:57–60. doi:10.1007/s12223-008-0008-z->
5. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:487–496. doi:10.1016/j.biomaterials.2007.08.050
6. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996–1006
7. Clinical and Laboratory Standards Institute (CLSI) (2012) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 9th ed. Approved standard, Villanova, PA
8. Cohen ML (2000) Changing patterns of infectious disease. Nature 406:762–767. doi:10.1038/35021206
9. Deshpande S, Patil S, Kuchibhatla S, Seal S (2005) Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide. Appl Phys Lett 87:1–3
10. Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D (2010) Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot (Tokyo) 63:423–430. doi:10.1038/ja.2010.62
11. Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61:377–392
12. Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40. doi:10.1016/j.tim.2004.11.010
13. Gokulakrishnan R, Ravikumar S, Raj JA (2012) In vitro antibacterial potential of metal oxide nanoparticles against antibiotic resistant bacterial pathogens. the. Asian Pac J Trop Dis 2:411–413
14. Gonzales-Weimuller M, Zeisberger M, Krishnan K (2009) Size-dependent heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J Magn Mag Mat 321:1947–1950
15. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021. doi:10.1016/j.biomaterials.2004.10.012
16. He S, Feng Y, Gu N, Zhang Y, Lin X (2011) The effect of gamma-Fe2O3 nanoparticles on Escherichia coli genome. Environ Pollut 159:3468–3473. doi:10.1016/j.envpol.2011.08.024
17. Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y, Yao Y, Huang D, Hao B (2008) Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 24:4140–4144. doi:10.1021/la7035949
18. Huh AJ, Kwon YJ (2011) “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156:128–145. doi:10.1016/j.jconrel.2011.07.002
19. Issa B, Obaidat IM, Albiss BA, Haik Y (2013) Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci 14:21266–21305. doi:10.3390/ijms141121266
20. Khandhar AP, Ferguson RM, Simon JA, Krishnan KM (2012) Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia. J Appl Phys 111:7B306–307B3063
21. Kuang Y, He X, Zhang Z, Li Y, Zhang H, Ma Y, Wu Z, Chai Z (2011) Comparison study on the antibacterial activity of nano- or bulk-cerium oxide. J Nanosci Nanotechnol 11:4103–4108
22. Kurek A, Grudniak AM, Kraczkiewicz-Dowjat A, Wolska KI (2011) New antibacterial therapeutics and strategies. Pol J Microbiol 60:3–12
23. Lode H (2001) Evidence of different profiles of side effects and drug-drug interactions among the quinolones–the pharmacokinetic standpoint. Chemotherapy 47:24–31; discussion 44–28
24. Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI (2013) In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide. Infect Drug Resist 6:27–32. doi:10.2147/IDR.S41501idr-6-027
25. Negahdary M, Mohseni G, Fazilati M, Parsania S, Rahimi G, Rad S, Rezaei-Zarchi S (2012) The Antibacterial effect of cerium oxide nanoparticles on Staphylococcus aureus bacteria. Ann Biol Res 3:3671–3678
26. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–557. doi:10.1038/nmat2442
27. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE (2007) Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 73:549–559. doi:10.1016/j.cardiores.2006.11.031
28. Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–1720. doi:10.1128/AEM.02218-06
29. Pareta RA, Taylor E, Webster TJ (2008) Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 19:265101. doi:10.1088/0957-4484/19/26/265101
30. Pelletier DA, Suresh AK, Holton GA, McKeown CK, Wang W, Gu B, Mortensen NP, Allison DP, Joy DC, Allison MR, Brown SD, Phelps TJ, Doktycz MJ (2010) Effects of engineered cerium oxide nanoparticles on bacterial growth and viability. Appl Environ Microbiol 76:7981–7989. doi:10.1128/AEM.00650-10
31. Perez JM, Asati A, Nath S, Kaittanis C (2008) Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small 4:552–556. doi:10.1002/smll.200700824
32. Ravikumar S, Gokulakrishnan R, Selvanathan K, Selvam S (2011) Antibacterial activity of metal oxide nanoparticles against ophthalmic pathogens. Int J Pharm Res Dev 3:122–127
33. Rispoli F, Angelov A, Badia D, Kumar A, Seal S, Shah V (2010) Understanding the toxicity of aggregated zero valent copper nanoparticles against Escherichia coli. J Hazard Mater 180:212–216. doi:10.1016/j.jhazmat.2010.04.016
34. Shah V, Shah S, Shah H, Rispoli FJ, McDonnell KT, Workeneh S, Karakoti A, Kumar A, Seal S (2012) Antibacterial activity of polymer coated cerium oxide nanoparticles. PLoS One 7:e47827. doi:10.1371/journal.pone.0047827PONE-D-12-17889
35. Subbiahdoss G, Sharifi S, Grijpma DW, Laurent S, van der Mei HC, Mahmoudi M, Busscher HJ (2012) Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater 8:2047–2055. doi:10.1016/j.actbio.2012.03.002
36. Tarnuzzer RW, Colon J, Patil S, Seal S (2005) Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 5:2573–2577. doi:10.1021/nl052024f
37. Taylor EN, Webster TJ (2009) The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine 4:145–152
38. Thill A, Zeyons O, Spalla O, Chauvat F, Rose J, Auffan M, Flank AM (2006) Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 40:6151–6156
39. Tran N, Mir A, Mallik D, Sinha A, Nayar S, Webster TJ (2010) Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine 5:277–283
40. Wang Q, Webster TJ (2013) Short communication: inhibiting biofilm formation on paper towels through the use of selenium nanoparticles coatings. Int J Nanomedicine 8:407–411. doi:10.2147/IJN.S38777ijn-8-407
41. Weir E, Lawlor A, Whelan A, Regan F (2008) The use of nanoparticles in anti-microbial materials and their characterization. Analyst 133:835–845. doi:10.1039/b715532h
42. Wu W, Li S, Liao S, Xiang F, Wu X (2010) Preparation of new sunscreen materials Ce12xZnxO22x via solid-state reaction at room temperature and study on their properties. Rare Met 29:149–153